article
3. Pemble, C.W. IV, Johnson, L.C., Kridel, S.J. & Lowther, W.T. Crystal structure
of the thioesterase domain of human fatty acid synthase inhibited by Orlistat.
Nat. Struct. Mol. Biol. 14, 704–709 (2007).
amide bond formation with 2,3-DHB, and cyclization to the mac-
rolactone47. Thus, only AAr and TAr domains have been shown to be
active in trans, supporting the existence of ObiF NRPS modules with
and without the AAr domain as part of the main NRPS module.
ItisconceivablethatothercatalyticdomainswithactivesiteCysres-
idues might catalyze cyclization of β-hydroxythioesters to β-lactones.
For example, an uncharacterized ketosynthase (KS) domain resides
at the C terminus of the ebelactone PKS termination module7. KS
domains undergo transthioesterification reactions with T domain
thioesters to form intermediate KS-Cys thioesters on a conserved
Cys–His–His triad48. KS domains typically catalyze thio-Claisen
condensations with malonyl T-domain thioesters, but might also be
capable of β-lactone ring forming condensations. The termination
module of the hybrid PKS–NRPS assembly line for oxazolomycin fea-
tures a C-terminal C domain of unknown function15. Condensation
domains typically catalyze amide bond formation between two T
domain thioesters, but there are documented cases of C domains cata-
lyzing cyclization during product release such as in cyclosporin A and
enniatin biosynthesis20. The oxazolomycin terminal C domain might
catalyze the intramolecular condensation of a T domain thioester to
the spirocyclic β-lactone. The salinosporamide biosynthetic gene clus-
ter encodes for several uncharacterized enzymes, including a stand-
alone KS domain, SalC, that might participate in bicyclic β-lactone
formation4,14. We predict that more β-lactone-forming “logic gates”
4. Gulder, T.A. & Moore, B.S. Salinosporamide natural products: Potent 20S
proteasome inhibitors as promising cancer chemotherapeutics. Angew. Chem.
Int. Edn Engl. 49, 9346–9367 (2010).
5. De Pascale, G., Nazi, I., Harrison, P.H. & Wright, G.D. β-Lactone natural
products and derivatives inactivate homoserine transacetylase, a target for
antimicrobial agents. J. Antibiot. (Tokyo) 64, 483–487 (2011).
6. Lall, M.S., Ramtohul, Y.K., James, M.N.G. & Vederas, J.C. Serine and
threonine β-lactones: a new class of hepatitis A virus 3C cysteine proteinase
inhibitors. J. Org. Chem. 67, 1536–1547 (2002).
7. Wyatt, M.A. et al. Biosynthesis of ebelactone A: isotopic tracer, advanced
precursor and genetic studies reveal a thioesterase-independent cyclization to
give a polyketide β-lactone. J. Antibiot. (Tokyo) 66, 421–430 (2013).
8. Hamed, R.B. et al. e enzymes of β-lactam biosynthesis. Nat. Prod. Rep. 30,
21–107 (2013).
9. Roach, P.L. et al. Structure of isopenicillin N synthase complexed with
substrate and the mechanism of penicillin formation. Nature 387,
827–830 (1997).
10. Bachmann, B.O., Li, R. & Townsend, C.A. β-Lactam synthetase: a new
biosynthetic enzyme. Proc. Natl. Acad. Sci. USA 95, 9082–9086 (1998).
11. Gaudelli, N.M., Long, D.H. & Townsend, C.A. β-Lactam formation by a
non-ribosomal peptide synthetase during antibiotic biosynthesis. Nature 520,
383–387 (2015).
12. Christenson, J.K. et al. β-Lactone synthetase found in the olefin biosynthesis
pathway. Biochemistry 56, 348–351 (2017).
13. Bai, T. et al. Operon for biosynthesis of lipstatin, the β-lactone inhibitor of
human pancreatic lipase. Appl. Environ. Microbiol. 80, 7473–7483 (2014).
will be discovered as part of NRPS–PKS modular assembly lines and 14. Eustáquio, A.S. et al. Biosynthesis of the salinosporamide A polyketide
possibly as autonomous catalysts10,16,49
.
synthase substrate chloroethylmalonyl-coenzyme A from S-adenosyl-L-
methionine. Proc. Natl. Acad. Sci. USA 106, 12295–12300 (2009).
15. Zhao, C. et al. Oxazolomycin biosynthesis in Streptomyces albus JA3453
featuring an “acyltransferase-less” type I polyketide synthase that incorporates
two distinct extender units. J. Biol. Chem. 285, 20097–20108 (2010).
16. Horsman, M.E., Hari, T.P. & Boddy, C.N. Polyketide synthase and
nonribosomal peptide synthetase thioesterase selectivity: logic gate or a
victim of fate? Nat. Prod. Rep. 33, 183–202 (2016).
Obi represents a novel structural class of β-lactone antibiotics
from nature’s chemical inventory. The Obi biosynthetic machin-
ery characterized in this study offers a versatile platform for the
chemoenzymatic synthesis of β-lactones from β-hydroxy-α-amino
acid precursors. Here, the new amino acid β-OH-p-NO2-homoPhe
was produced by a threonine aldolase, possibly representing a gen-
eral strategy for producing β-hydroxy-α-amino acid precursors to
peptide β-lactones. Fe(II)/α-KG-dependent oxygenases and non-
heme di-iron oxygenases are also known to produce β-hydroxy-
α-amino acids via direct C–H bond activation chemistry on free
amino acids50,51. Hydroxylation of amino acid side chains can also
take place while loaded as thioesters on NRPS T domains, making A
domain substrate prediction insufficient for the potential incorpo-
ration of β-hydroxy-α-amino acids into NRP scaffolds52. Our work
shows that β-hydroxy-α-amino acids can be directly incorporated
into peptide scaffolds on an NRPS assembly line, leading to peptides
capped at the C terminus with a β-lactone warhead. Our genetic and
biochemical characterization of the Obi biosynthetic pathway in
P. fluorescens will guide future genome mining efforts and expands
the known chemistry of NRPS and PKS product release mecha-
nisms to include strained 4-membered ring formation10,20,24. Our
chemoenzymatic approach to C-terminal β-lactone peptides has the
potential for applications in precursor-directed feeding studies and
NRPS engineering to produce targeted peptide β-lactone inhibitors
of proteases for the treatment of diseases associated with microbial
and viral infections5,6,25, cancer4, and obesity3.
17. Jiang, Y., Morley, K.L., Schrag, J.D. & Kazlauskas, R.J. Different active-site
loop orientation in serine hydrolases versus acyltransferases. ChemBioChem
12, 768–776 (2011).
18. Gaudelli, N.M. & Townsend, C.A. Epimerization and substrate gating
by a TE domain in β-lactam antibiotic biosynthesis. Nat. Chem. Biol. 10,
251–258 (2014).
19. Jensen, K. et al. Polyketide proofreading by an acyltransferase-like enzyme.
Chem. Biol. 19, 329–339 (2012).
20. Kopp, F. & Marahiel, M.A. Macrocyclization strategies in polyketide
and nonribosomal peptide biosynthesis. Nat. Prod. Rep. 24, 735–749
(2007).
21. Dick, L.R. et al. Mechanistic studies on the inactivation of the proteasome by
lactacystin: a central role for clasto-lactacystin β-lactone. J. Biol. Chem. 271,
7273–7276 (1996).
22. Wells, J.S., Trejo, W.H., Principe, P.A. & Sykes, R.B. Obafluorin, a novel
β-lactone produced by Pseudomonas fluorescens. Taxonomy, fermentation and
biological properties. J. Antibiot. (Tokyo) 37, 802–803 (1984).
23. Tymiak, A.A., Culver, C.A., Malley, M.F. & Gougoutas, J.Z. Structure of
obafluorin: an antibacterial β-lactone from Pseudomonas fluorescens.
J. Org. Chem. 50, 5491–5495 (1985).
24. Dejong, C.A. et al. Polyketide and nonribosomal peptide retro-biosynthesis
and global gene cluster matching. Nat. Chem. Biol. 12, 1007–1014 (2016).
25. Hamed, R.B. et al. Crotonase catalysis enables flexible production
of functionalized prolines and carbapenams. J. Am. Chem. Soc. 134,
471–479 (2012).
26. Pu, Y., Lowe, C., Sailer, M. & Vederas, J.C. Synthesis, stability, and
antimicrobial activity of (+)-obafluorin and related β-lactone antibiotics.
J. Org. Chem. 59, 3642–3655 (1994).
received 1 June 2016; accepted 7 March 2017;
published online 15 May 2017
27. Herbert, R.B. & Knaggs, A.R. Biosynthesis of the antibiotic obafluorin from
D-[U-13C]glucose and p-aminophenylalanine in Pseudomonas fluorescens.
J. Chem. Soc. Perkin Trans. I 1992, 103–107 (1992).
mETHODS
28. Herbert, R.B. & Knaggs, A.R. Biosynthesis of the antibiotic obafluorin from
p-aminophenylalanine and glycine (glyoxylate). J. Chem. Soc. Perkin Trans. I
1992, 109–113 (1992).
29. Bentley, R. e shikimate pathway—a metabolic tree with many branches.
Crit. Rev. Biochem. Mol. Biol. 25, 307–384 (1990).
references
30. Walsh, C.T., Liu, J., Rusnak, F. & Sakaitani, M. Molecular studies on enzymes
in chorismate metabolism and the enterobactin biosynthetic pathway.
Chem. Rev. 90, 1105–1129 (1990).
1. Lowe, C. & Vederas, J.C. Naturally occuring β-lactones: occurence, synthesis
and properties. A review. Org. Prep. Proced. Int. 27, 305–346 (1995).
2. Bachovchin, D.A. et al. Superfamily-wide portrait of serine hydrolase
inhibition achieved by library-versus-library screening. Proc. Natl. Acad.
Sci. USA 107, 20941–20946 (2010).
31. Fernández-Martínez, L.T. et al. New insights into chloramphenicol
biosynthesis in Streptomyces venezuelae ATCC 10712. Antimicrob. Agents
Chemother. 58, 7441–7450 (2014).
nature CHeMICaL BIOLOGY | AdvAnce online publicAtion | www.nature.com/naturechemicalbiology
7